These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8453580)

  • 1. Dysgerminoma of the ovary. An immunohistochemical study of tumor-infiltrating lymphoreticular cells and tumor cells.
    Dietl J; Horny HP; Ruck P; Kaiserling E
    Cancer; 1993 Apr; 71(8):2562-8. PubMed ID: 8453580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of gamma/delta T cells in human dysgerminoma and seminoma: roles in autologous tumor killing and granuloma formation.
    Zhao X; Wei YQ; Kariya Y; Teshigawara K; Uchida A
    Immunol Invest; 1995 May; 24(4):607-18. PubMed ID: 7622197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the inflammatory infiltrate in ovarian dysgerminoma: an immunocytochemical study.
    Stewart CJ; Farquharson MA; Foulis AK
    Histopathology; 1992 Jun; 20(6):491-7. PubMed ID: 1607150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
    Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH
    Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistological analysis of tumour infiltrating lymphocytes in seminoma using monoclonal antibodies.
    Nakanoma T; Nakamura K; Deguchi N; Fujimoto J; Tazaki H; Hata J
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):409-13. PubMed ID: 1455691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation potential of ovarian dysgerminoma: an immunohistochemical study of 15 cases.
    Lifschitz-Mercer B; Walt H; Kushnir I; Jacob N; Diener PA; Moll R; Czernobilsky B
    Hum Pathol; 1995 Jan; 26(1):62-6. PubMed ID: 7821917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating lymphocytes and histocompatibility antigens in primary intracranial germinomas.
    Saito T; Tanaka R; Kouno M; Washiyama K; Abe S; Kumanishi T
    J Neurosurg; 1989 Jan; 70(1):81-5. PubMed ID: 2909691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of seminoma and its inflammatory cell infiltrate.
    Bell DA; Flotte TJ; Bhan AK
    Hum Pathol; 1987 May; 18(5):511-20. PubMed ID: 3552955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
    Webb JR; Milne K; Kroeger DR; Nelson BH
    Gynecol Oncol; 2016 May; 141(2):293-302. PubMed ID: 26972336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin and CD30 expression in dysgerminoma.
    Cossu-Rocca P; Jones TD; Roth LM; Eble JN; Zheng W; Karim FW; Cheng L
    Hum Pathol; 2006 Aug; 37(8):1015-21. PubMed ID: 16867864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistologic characterization of lymphoid cells infiltrating dysgerminoma of the ovary].
    Honma S; Uchiyama M; Omomo Y; Watanabe S; Sasagawa M; Kanazawa K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2201-6. PubMed ID: 3543166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
    Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
    Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy.
    Lo CS; Sanii S; Kroeger DR; Milne K; Talhouk A; Chiu DS; Rahimi K; Shaw PA; Clarke BA; Nelson BH
    Clin Cancer Res; 2017 Feb; 23(4):925-934. PubMed ID: 27601594
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammatory infiltrate of chronic periradicular lesions: an immunohistochemical study.
    Liapatas S; Nakou M; Rontogianni D
    Int Endod J; 2003 Jul; 36(7):464-71. PubMed ID: 12823701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
    List AF; Spier CM; Miller TP; Grogan TM
    Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas.
    Ohmori T; Okada K; Arita N; Watanabe Y; Miyazaki T; Tabei R
    Histol Histopathol; 1995 Oct; 10(4):789-94. PubMed ID: 8573998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
    Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
    Kataki A; Scheid P; Piet M; Marie B; Martinet N; Martinet Y; Vignaud JM
    J Lab Clin Med; 2002 Nov; 140(5):320-8. PubMed ID: 12434133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.